Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_provenance.
- NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_assertion wasGeneratedBy ECO_0000203 NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_provenance.
- NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_assertion wasDerivedFrom befree-20140225 NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_provenance.
- NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_assertion SIO_000772 8664297 NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_provenance.
- NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_assertion evidence source_evidence_literature NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_provenance.
- NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_assertion description "[Using cloned fragments from the myotonic dystrophy (DM) and fragile X syndrome (FRAXA) loci containing normal, premutation, and full mutation lengths of repeats, we report the formation of novel alternative DNA secondary structures that map within the repeat tracts during reannealing of complementary strands, containing equal lengths of repeats, into linear duplex DNA molecules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_provenance.
- befree-20140225 importedOn "2014-02-25" NP665967.RAfOPr8vnj5lmHKMHac4YcoX694v5hMfyuH2_xqL-cu3k130_provenance.